376 related articles for article (PubMed ID: 32516772)
1. SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?
Busetto GM; Porreca A; Del Giudice F; Maggi M; D'Agostino D; Romagnoli D; Musi G; Lucarelli G; Palmer K; Colonna di Paliano A; Muto M; Hurle R; Terracciano D; de Cobelli O; Sciarra A; De Berardinis E; Ferro M
Urol Int; 2020; 104(7-8):510-522. PubMed ID: 32516772
[TBL] [Abstract][Full Text] [Related]
2. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
Pugliese G; Vitale M; Resi V; Orsi E
Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.
Zhou Y; Zhang Z; Tian J; Xiong S
Ann Palliat Med; 2020 Mar; 9(2):428-436. PubMed ID: 32233642
[TBL] [Abstract][Full Text] [Related]
4. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
5. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
6. Severe COVID-19 and aging: are monocytes the key?
Pence BD
Geroscience; 2020 Aug; 42(4):1051-1061. PubMed ID: 32556942
[TBL] [Abstract][Full Text] [Related]
7. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
Almerie MQ; Kerrigan DD
Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
[TBL] [Abstract][Full Text] [Related]
8. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
9. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.
Pasquarelli-do-Nascimento G; Braz-de-Melo HA; Faria SS; Santos IO; Kobinger GP; Magalhães KG
Front Endocrinol (Lausanne); 2020; 11():530. PubMed ID: 32849309
[TBL] [Abstract][Full Text] [Related]
10. Does High Cardiorespiratory Fitness Confer Some Protection Against Proinflammatory Responses After Infection by SARS-CoV-2?
Zbinden-Foncea H; Francaux M; Deldicque L; Hawley JA
Obesity (Silver Spring); 2020 Aug; 28(8):1378-1381. PubMed ID: 32324968
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inflammatory response in associated comorbidities in COVID-19.
de Lucena TMC; da Silva Santos AF; de Lima BR; de Albuquerque Borborema ME; de Azevêdo Silva J
Diabetes Metab Syndr; 2020; 14(4):597-600. PubMed ID: 32417709
[TBL] [Abstract][Full Text] [Related]
12. Association between obesity and clinical prognosis in patients infected with SARS-CoV-2.
Cai SH; Liao W; Chen SW; Liu LL; Liu SY; Zheng ZD
Infect Dis Poverty; 2020 Jun; 9(1):80. PubMed ID: 32600411
[TBL] [Abstract][Full Text] [Related]
13. Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu.
Leyfman Y; Erick TK; Reddy SS; Galwankar S; Nanayakkara PWB; Di Somma S; Sharma P; Stawicki SP; Chaudry IH
Shock; 2020 Oct; 54(4):438-450. PubMed ID: 32649367
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho AF; Maes M; Walder K; Berk M
Life Sci; 2020 Oct; 258():118166. PubMed ID: 32739471
[TBL] [Abstract][Full Text] [Related]
15. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.
Korakas E; Ikonomidis I; Kousathana F; Balampanis K; Kountouri A; Raptis A; Palaiodimou L; Kokkinos A; Lambadiari V
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E105-E109. PubMed ID: 32459524
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and the role of chronic inflammation in patients with obesity.
Chiappetta S; Sharma AM; Bottino V; Stier C
Int J Obes (Lond); 2020 Aug; 44(8):1790-1792. PubMed ID: 32409680
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
Song SH; Chen TL; Deng LP; Zhang YX; Mo PZ; Gao SC; Hu WJ; Xiong Y; Ma ZY
Infect Dis Poverty; 2020 Jul; 9(1):82. PubMed ID: 32616030
[TBL] [Abstract][Full Text] [Related]
18. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
19. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.
Lisco G; De Tullio A; Giagulli VA; Guastamacchia E; De Pergola G; Triggiani V
Endocrine; 2020 Dec; 70(3):441-453. PubMed ID: 32779091
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings.
Öztürk R; Taşova Y; Ayaz A
Turk J Med Sci; 2020 Apr; 50(SI-1):638-657. PubMed ID: 32512673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
